Zusammenfassung
In der kardiovaskulären Medizin und insbesondere im Rahmen der invasiven Behandlung der koronaren Herzkrankheit stellt die intraaortale Ballongegenpulsation (IABP) ein vielfach bewährtes Verfahren dar, welches auch heute im Zeitalter der mechanischen Herz-Kreislauf-Unterstützung noch immer eine wichtige Rolle im klinischen Alltag spielt. Sie kommt hierbei sowohl periinterventionell im Herzkatheterlabor als auch perioperativ im Rahmen einer chirurgischen Revaskularisation zunehmend zum Einsatz. Die Ballonpumpe unterstützt invasiv die Hämodynamik des Patienten durch eine Steigerung von diastolischer Perfusion und diastolischem Blutdruck. Diese Mechanismen bewirken eine Verbesserung der Koronarperfusion während der Diastole und eine Reduzierung der Nachlast des Herzens. Die Wirksamkeit der IABP konnte in einer Vielzahl klinischer Situationen bewiesen werden. Als klassische Indikationen gelten: akutes Koronarsyndrom, sog. High-risk-Koronarinterventionen im Rahmen einer Herzkatheteruntersuchung, kardiogener Schock und der gesamte perioperative Bereich innerhalb der Herzchirurgie. Die möglichen Komplikationen der intraaortalen Gegenpulsation können durchaus schwerwiegend sein, obwohl sie in ihrer Inzidenz deutlich abgenommen haben. Bei sorgfältiger Patientenselektion und Implantationstechnik stellt die IABP eine effektive Therapieoption in der Behandlung von Patienten mit kardiovaskulären Erkrankungen dar. Die folgende Arbeit fasst die hämodynamischen Veränderungen, Indikationen, Komplikationen und Ergebnisse bei der Verwendung der IABP zusammen.
Abstract
In cardiovascular medicine and coronary intervention, the intraaortic balloon pump (IABP) is a proven technology that plays an important role in circulatory support. The balloon pump invasively supports patient hemodynamics by augmenting diastolic perfusion and increasing diastolic blood pressure, thereby increasing coronary perfusion and reducing afterload. Its efficacy has been demonstrated in a multitude of clinical situations, including acute coronary syndromes, high-risk coronary interventions, cardiogenic shock, and cardiovascular surgery. The potential complications of aortic counterpulsation are serious, although much lower than in former times. With proper patient selection, insertion technique, and management, the IABP is a powerful device to assist in the treatment of patients with cardiovascular disease. Hemodynamics, indications, complications, and results associated with IABP use are reviewed.
Literatur
Kantrowitz A, Tjonneland S, Freed PS et al (1968) Initial clinical experience with intra-aortic balloon pumping in cardiogenic shock. JAMA 203:135–140
Fergusson JJ, Cohen M, Freedman RJ et al (2001) The current practice of intra-aortic balloon counterpulsation: Results from the Benchmark registry. J Am Coll Cardiol 38:1456–1462
Kantrowitz A (1953) Experimental augmentation of coronary blood flow by retardation of the arterial pressure pulse. Surgery 34:678–687
Moulopolous SD, Topaz S, Kolff WJ (1962) Diastolic balloon pumping in the aorta – A mechanical assistance to the failing circulation. Am Heart J 63:669–657
Clauss RH, Missier P, Reed GE, Tice A (1962) Assisted circulation by counterpulsation with an intra-aortic balloon. Methods and effects. In: Digest, 15th. annual conference on engineering in medicine and biology; Chicago, S 444
Schilt W, Freed PS, Khalil G, Kantrowitz A (1967) Temporary non-surgical intra-arterial cardiac assistance. Trans Am Soc Artif Intern Org 13:322–327
Borowski A, Ruhparwar A, Korb H (1995) Mechanical circulatory support: Intra-aortic balloon counterpulsation. Zentralbl Chir 120:159–165 (article in German)
Bolooki H (1984) Physiology of balloon pumping. In: Bolooki H (Hrsg) Clinical application of intra-aortic balloon pump. Mount Kisco, New-York, S 57–126
Sasayama S, Osakada G, Takahashi M et al (1979) Effects of intra-aortic balloon counterpulsation on regional myocardial function during acute coronary occlusion in the dog. Am J Cardiol 43:59–66
Kern MJ, Henry RH, Lembo N et al (1985) Effects of pulsed external augmentation of diastolic pressure on coronary and systemic hemodynamics in patients with coronary artery disease. Am Heart J 110:727–735
Benn A, Feldmann T (1992) The technique of inserting an intra-aortic balloon pump. Indications, contraindications, advice for avoiding complications. J Crit Illn 7:435–445
Akomea-Agyin C, Kejriwal NK, Franks R et al (1999) Intra-aortic balloon pumping in children. Ann Thorac Surg 67:1415–1420
Pantalos GM, Minich LL, Tani LY et al (1999) Estimation of timing errors for the intra-aortic balloon pump use in pediatric patients. ASAIO J 45:166–171
Baskett RJ, Ghali WA, Maitland A, Hirsch GM (2002) The intra-aortic balloon pump in cardiac surgery. Ann Thorac Surg 74:1276–1287
Crystal E, Borer A, Gilad J et al (2000) Incidence and clinical significance of bacteremia and sepsis among cardiac patients treated with intra-aortic counterpulsation pump. Am J Cardiol 86:1281–1284
Torchiana DF, Hirsch G, Buckley MJ (1997) Intra-aortic balloon pumping for cardiac support: Trends in practice and outcome, 1968 to 1995. J Thorac Cardiovasc Surg 113:758–769
Stone GW, Marsalese D, Brodie BR et al (1997) A prospective, randomized evaluation of prophylactic intra-aortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI II) Trial Investigators. J Am Coll Cardiol 29:1459–1467
Grines CL (1996) Aggressive intervention for myocardial infarction: Angioplasty, stents and intra-aortic balloon pumping. Am J Cardiol 14:29–34
Holmes DR, Califf RM, van de Werf F (1997) Difference in countries‘ use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction. Results from the GUSTO trial. Lancet 349:75–78
Hochmann JS, Buller CE, Sleeper LA et al (2000) Cardiogenic shock complicating acute myocardial infarction – etiologies, management and outcome: A report from the SHOCK trial registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 36 (Suppl 3A):1063–1070
Naunheim KS, Schwartz MT, Pennington DE (1992) Intra-aortic balloon pumping in patients requiring cardiac operations. Risk analysis and long term follow-up. J Thorac Cardiovasc Surg 104:1654–1671
Creswell LL, Rosenbloom M, Cox JL (1992) Intra-aortic balloon counterpulsation: Patterns of usage and outcome in cardiac surgery patients. Ann Thorac Surg 54:11–20
Dietl CA, Berkheimer MD, Woods EL et al (1996) Efficacy and cost effectiveness of preoperative IABP in patients with ejection fraction of 0,25 or less. Ann Thorac Surg 62:401–409
Baldwin RT, Slogoff S, Noon GP (1993) A modell to predict survival at time of postcardiotomy intra-aortic balloon pump insertion. Ann Thorac Surg 55:908–913
Busch T, Sirbu H, Zenker D, Dalichau H (1997) Vascular complications related to intra-aortic balloon counterpulsation: An analysis of ten years experience. Thorac Cardiovasc Surg 45:55–59
Mark B, Zahn R, Dönges K et al (2000) Current use and critical view of the intra-aortic counterpulsation in cardiologic routine. Med Klin 95:429–434 (article in German)
Georgeson S, Coombs AT, Eckman MH (1992) Prophylactic use of the intra-aortic balloon pump in high risk cardiac patients undergoing non cardiac surgery: A decision analytic view. Am J Med 92:665–678
Holman WL, Li Q, Kiefe CI, Mc Giffin DC (2000) Prophylactic value of preincision of an intra-aortic balloon pump: Analysis and statewide experience. J Thorac Cardiovasc Surg 120:1112–1119
Hausmann H, Potapov EV, Koster A et al (2002) Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation 106:I203–I206
Meharwal ZS, Trehan N (2002) Vascular complications of intra-aortic balloon insertion in patients undergoing coronary revascularization. Eur J Cardiothorac Surg 21:741–747
Barnett MG, Swartz MT, Peterson GJ et al (1994) Vascular complications from intra-aortic balloons: Risk analysis. J Vasc Surg 19:81–87
Sirbu H, Busch T, Aleksic I (2000) Ischemic complications with intra-aortic balloon counterpulsation: Incidence and management. Cardiovasc Surg 8:66–71
Bur A, Bayegan K, Holzer M (2002) Intra-aortic balloon counterpulsation in the emergency department: A 7 year review and analysis of predictors of survival. Resuscitation 53:259–264
Talley JD, Ohman EM, Mark DB et al (1997) Economic implications of the prophylactic use of intra-aortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intra-aortic balloon pump. Am J Cardiol 79:590–594
Christenson JT, Simonet F, Schmuziger M (2000) Economic impact of preoperative intra-aortic balloon pump therapy in high-risk coronary patients. Ann Thorac Surg 70:510–515
Dembitsky W (1999) Bridging from acute to chronic devices. Ann Thorac Surg 68:724–728
Farrar D, Hill J (1993) Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg 55:276–282
Stone GW, Ohman EM, Miller MF et al (2003) Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. J Am Coll Cardiol 41:1940–1945
Urban PM, Freedman RJ, Ohman EM et al (2004) In-hospital mortality associated with the use of intra-aortic balloon counterpulsation. Am J Cardiol 94:181–185
Santa-Cruz RA, Cohen MG, Ohman EM (2006) Aortic counterpulsation: a review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv 67(1):68–77 (review)
Trost JC, Hillis LD (2006) Intra-aortic balloon counterpulsation. Am J Cardiol 97(9):1391–1398 (review)
Litmathe J, Feindt P, Boeken U, Gams E (2003) Mechanical heart support using intra-aorticc counterpulsation. A retrospective view and current perspectives. Acta Cardiol 59(2):159–164
Van de Werf F, Bax J, Betriu A et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29(23):2909–2945
Antman EM, Anbe DT, Armstrong PW et al (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 110(5):588–636
Interessenkonflikt
Der Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boeken, U., Feindt, P., Schurr, P. et al. Mechanische Herz-Kreislauf-Unterstützung mittels intraaortaler Ballongegenpulsation. Z Herz- Thorax- Gefäßchir 24, 58–65 (2010). https://doi.org/10.1007/s00398-009-0754-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00398-009-0754-5